Loading stock data…
CC
$20.22-0.64 (-3.07%)
After Hours$20.22+0.00 (+0.00%)· Last close Jun 9
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
The Chemours Company in the Basic Materials sector is trading at $20.22. Wall Street consensus targets $26.33 (9 analysts), implying a +30.2% move over the next 12 months. The stock is currently 29% below its 52-week high of $28.67, remaining 18.5% above its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 85/100 reflects bullish alignment across trend, valuation and analyst targets.
Ecosystem Influences
Sell-side targets imply +30.2% upside over 12 months
Long-term trend bullish (price vs 200-day SMA)
Macro-economic sensitivity to interest rate and inflation shifts
Loading Financials...
Peer Comparison
Whystock Valuation Model
Anchored to each ticker's own 5-year median trailing P/E, tilted by current ROE and growth. Fair P/E = own median P/E + (ROE × 10) + (max(revenue growth, earnings growth) × 15), capped at ±30% around the historical anchor. Fair Value = (Current Price ÷ Trailing P/E) × Fair P/E. Premium compounders like COST/MSFT are judged against their own multi-year norm rather than a sector median. Falls back to the sector-anchored formula (Tech ≈ 28, Comm Services ≈ 24, Utilities ≈ 18, Financials ≈ 14, etc.) for recent IPOs and tickers with insufficient history (< 24 monthly samples). Result is a normalised multiple gauge — not a price target.
Current Price$20.22
Potential Downside
0%
Whystock Fair Value$20.22
Price
UndervaluedFair ValueOvervalued
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Analyst Consensus9 analysts
Buy
Mean target$26.33+30.2%
Range$21.00 – $30.00
Fundamentals
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. The company operates through three segments: Thermal & Specialized Solutions, Titanium Technologies, and Advan...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
-
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
1.34%
ROE
Average efficiency. Growth may require heavy reinvestment.
-191.16%
Volume
Today's trading volume
2.97M
Recent News
Chemours (CC) Down 4.5% Since Last Earnings Report: Can It Rebound?
Chemours (CC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Trump’s Manufacturing Push Is Creating Tailwinds for These 3 Stocks Under $30
American manufacturing is having a moment. Reshoring incentives, the AIM Act refrigerant transition, EV plant buildouts, and aerospace demand are pushing capital back into U.S. factories, yet the share prices of several domestic producers still sit in deep-value territory. With manufacturing contributing $2,961.4 billion to GDP in Q4 2025 and policy tailwinds aligning, stocks under ... Trump’s Manufacturing Push Is Creating Tailwinds for These 3 Stocks Under $30
Do These 3 Checks Before Buying The Chemours Company (NYSE:CC) For Its Upcoming Dividend
Some investors rely on dividends for growing their wealth, and if you're one of those dividend sleuths, you might be...
Chemours Q1 Earnings Call Highlights
Chemours (NYSE:CC) said it opened 2026 with first-quarter results that were “well above earnings expectations,” driven by strong execution in its Thermal & Specialized Solutions and Titanium Technologies segments, while Advanced Performance Materials continued to recover from an outage at the co
Results: The Chemours Company Delivered A Surprise Loss And Now Analysts Have New Forecasts
It's been a sad week for The Chemours Company ( NYSE:CC ), who've watched their investment drop 17% to US$22.41 in the...